- -

High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 1: Perfusion and Diffusion Techniques

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Compartir/Enviar a

Citas

Estadísticas

  • Estadisticas de Uso

High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 1: Perfusion and Diffusion Techniques

Mostrar el registro completo del ítem

Henriksen, OM.; Álvarez-Torres, MDM.; Figueiredo, P.; Hangel, G.; Keil, VC.; Nechifor, RE.; Riemer, F.... (2022). High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 1: Perfusion and Diffusion Techniques. Frontiers in Oncology. 12. https://doi.org/10.3389/fonc.2022.810263

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/204344

Ficheros en el ítem

Metadatos del ítem

Título: High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 1: Perfusion and Diffusion Techniques
Autor: Henriksen, Otto M. Álvarez-Torres, María del Mar Figueiredo, Patricia Hangel, Gilbert Keil, Vera C. Nechifor, Ruben E. Riemer, Frank Schmainda, Kathleen M. Warnert, Esther A. H. Wiegers, Evita C. Booth, Thomas C.
Fecha difusión:
Resumen:
[EN] Objective: Summarize evidence for use of advanced MRI techniques as monitoring biomarkers in the clinic, and highlight the latest bench-to-bedside developments. Methods: Experts in advanced MRI techniques applied to ...[+]
Palabras clave: Magnetic resonance imaging , Glioma , Perfusion , Diffusion , Pseudoprogression , Monitoring biomarkers , Glioblastoma , High-grade glioma
Derechos de uso: Reconocimiento (by)
Fuente:
Frontiers in Oncology. (eissn: 2234-943X )
DOI: 10.3389/fonc.2022.810263
Editorial:
Frontiers Media SA
Versión del editor: https://doi.org/10.3389/fonc.2022.810263
Código del Proyecto:
info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F50009%2F2020/PT/Laboratory of Robotics and Engineering Systems/
...[+]
info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F50009%2F2020/PT/Laboratory of Robotics and Engineering Systems/
info:eu-repo/grantAgreement/NIH/NATIONAL_CANCER_INSTITUTE/1R01CA255123-01A1/US/New treatment monitoring biomarkers for brain tumors using multiparametric MRI with machine learning/
info:eu-repo/grantAgreement/NIH/NATIONAL_CANCER_INSTITUTE/1U01CA176110-01A1/US/Quantitative (Perfusion and Diffusion) MRI Biomarkers to Measure Glioma Response/
info:eu-repo/grantAgreement/NIH/NATIONAL_CANCER_INSTITUTE/1UG3CA247606-01/US/Multi-parametric Perfusion MRI for Therapy Response Assessment in Brain Cancer/
info:eu-repo/grantAgreement/NWO//18144/NL
info:eu-repo/grantAgreement/NWO//91619121/
info:eu-repo/grantAgreement/EPSRC//WT 203148%2FZ%2F16%2FZ/
info:eu-repo/grantAgreement/COST//CA18206/
info:eu-repo/grantAgreement/FWF//KLI-646/
info:eu-repo/grantAgreement/AEI//DPI2016-80054-R//BIOMARCADORES DINAMICOS BASADOS EN FIRMAS TISULARES MULTIPARAMETRICAS PARA EL SEGUIMIENTO Y EVALUACION DE LA RESPUESTA A TRATAMIENTO DE PACIENTES CON GLIOBLASTOMA Y CANCER DE PROSTATA/
info:eu-repo/grantAgreement/Universitatea Babes-Bolyai//35277%2F18.11.2020/
[-]
Agradecimientos:
This publication is part of the COST Action CA18206 Glioma MR Imaging 2.0 (www.glimr.eu), supported by COST (European Cooperation in Science and Technology), www.cost.eu. GliMR provided travel and accommodation for members ...[+]
Tipo: Artículo

recommendations

 

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro completo del ítem